Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senad Handanagic

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2018
Latent Classes of Sexual Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Among Women Who Inject Drugs Across 20 US CitiesMary Ellen Mackesy-Amiti, Basmattee Boodram, Senad Handanagic, et al.
Journal of Viral Hepatitis|September 4, 2025
Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co-Infection, Georgia, 2017-2023Senad Handanagic, Shaun Shadaker, Davit BaliashvilI, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 27, 2023
Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015Josephine G Walker, Irina Tskhomelidze, Shaun Shadaker, et al.
Journal of Infection in Developing Countries|June 2, 2025
Risk factors for HCV infection in Georgia: A case-control studyMaia Butsashvili, Giorgi Kanchelashvili, Ketevan Galdavadze, et al.
The Lancet. Gastroenterology & Hepatology|July 13, 2025
Temporal trends in hepatitis C incidence among people tested more than once in Georgia, 2017-23: a nationwide, retrospective cohortDavit Baliashvili, Shaun Shadaker, Nathan Furukawa, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 15, 2024
Trends in new hepatitis C virus infections among repeat blood donors - Georgia, 2017-2023Shaun Shadaker, Davit Baliashvili, Maia Alkhazashvili, et al.
The International Journal on Drug Policy|May 11, 2016
HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveysSenad Handanagic, Ivana Bozicevic, Marta Civljak, et al.
The International Journal on Drug Policy|March 26, 2024
Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities-National HIV Behavioral Surveillance, 2018Johanna Chapin-Bardales, Alice Asher, Dita Broz, et al.
American Journal of Preventive Medicine|October 23, 2021
Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without ThemDita Broz, Neal Carnes, Johanna Chapin-Bardales, et al.
Journal of Infection Prevention|September 25, 2024
Hepatitis B and hepatitis C testing practices and observed seroconversions among dialysis facilities in GeorgiaMaia Butsashvili, Giorgi Kanchelashvili, Ana Aslanikashvili, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2018
Latent Classes of Sexual Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Among Women Who Inject Drugs Across 20 US CitiesMary Ellen Mackesy-Amiti, Basmattee Boodram, Senad Handanagic, et al.
Journal of Viral Hepatitis|September 4, 2025
Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co-Infection, Georgia, 2017-2023Senad Handanagic, Shaun Shadaker, Davit BaliashvilI, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 27, 2023
Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015Josephine G Walker, Irina Tskhomelidze, Shaun Shadaker, et al.
Journal of Infection in Developing Countries|June 2, 2025
Risk factors for HCV infection in Georgia: A case-control studyMaia Butsashvili, Giorgi Kanchelashvili, Ketevan Galdavadze, et al.
The Lancet. Gastroenterology & Hepatology|July 13, 2025
Temporal trends in hepatitis C incidence among people tested more than once in Georgia, 2017-23: a nationwide, retrospective cohortDavit Baliashvili, Shaun Shadaker, Nathan Furukawa, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 15, 2024
Trends in new hepatitis C virus infections among repeat blood donors - Georgia, 2017-2023Shaun Shadaker, Davit Baliashvili, Maia Alkhazashvili, et al.
The International Journal on Drug Policy|May 11, 2016
HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveysSenad Handanagic, Ivana Bozicevic, Marta Civljak, et al.
The International Journal on Drug Policy|March 26, 2024
Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities-National HIV Behavioral Surveillance, 2018Johanna Chapin-Bardales, Alice Asher, Dita Broz, et al.
American Journal of Preventive Medicine|October 23, 2021
Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without ThemDita Broz, Neal Carnes, Johanna Chapin-Bardales, et al.
Journal of Infection Prevention|September 25, 2024
Hepatitis B and hepatitis C testing practices and observed seroconversions among dialysis facilities in GeorgiaMaia Butsashvili, Giorgi Kanchelashvili, Ana Aslanikashvili, et al.
Pageof 4